Manaus
Manaus
Manaus, Brazil13 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) | Arterial Occlusive Diseases, Chronic Disease, Death, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, arteriosclerosis disorder, atherosclerosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, chronic renal failure syndrome, coronary artery disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, kidney disorder, kidney failure, metabolic disease, myocardial ischemia, nervous system disorder, peripheral arterial disease, peripheral vascular disease, type 2 diabetes mellitus, urinary system disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-10-08 | NCT06383390 | |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | Nutritional and Metabolic Diseases, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, metabolic disease, type 2 diabetes mellitus, vascular disorder | Recruiting | Phase 3 | 2026-09-30 | NCT07064473 | |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-24 | NCT07157774 | |
| Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia | Chemotherapy Induced Alopecia; Chemotherapy Side Effects | Recruiting | Phase 1 / Phase 2 | 2026-08-21 | NCT07397325 | |
| A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-28 | NCT06644768 | |
| Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus) | AIDS, Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Genital Diseases, HIV infectious disease, Hepadnaviridae infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, hepatitis, hepatitis B virus infection, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, liver disorder, sexually transmitted disease, uterine carcinosarcoma, viral hepatitis, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 2 | 2026-07-08 | NCT06497504 | |
| A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 2 | 2026-07-07 | NCT06537414 | |
| Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) | Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 2 | 2026-06-24 | NCT04954859 | |
| An Adapted Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Familial Hypercholesterolemia (DICA-FH) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, familial hypercholesterolemia, hereditary disease, hyperlipidemia, hyperlipoproteinemia, inborn errors of metabolism, metabolic disease | Active, not recruiting | Not applicable | 2026-05-12 | NCT06331195 | |
| Shorter and Safer Treatment Regimens for Latent TB | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, disease arising from reactivation of latent virus, gram-positive bacterial infections, latent tuberculosis infection, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 2 / Phase 3 | 2026-05-11 | NCT06498414 | |
| Pharmacokinetic Study of DA-020 | Chemotherapy Induced Alopecia; Chemotherapy Side Effects | Not yet recruiting | Early phase 1 | 2026-04-13 | NCT07402330 | |
| Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases. | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, G6PD deficiency, Hemic and Lymphatic Diseases, Infections, Mosquito-Borne Diseases, Nutritional and Metabolic Diseases, Plasmodium vivax malaria, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, malaria, metabolic disease, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 4 | 2026-03-12 | NCT07468513 | |
| A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria | Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 3 | 2025-07-18 | NCT06148792 |